YI
Therapeutic Areas
PAM Theragnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PAM Therapy | Alzheimer's Disease | Pre-clinical |
Leadership Team at PAM Theragnostics
AB
Andreas Bergmann
Chief Executive Officer
PK
Paul Kaufmann
Head of Operations
MP
Michaela Press
R&D Scientist